Login / Signup

Two Hematological Markers Predicting the Efficacy and Prognosis of Neoadjuvant Chemotherapy Using Lobaplatin Against Triple-Negative Breast Cancer.

Cheng WangQiyun ShiGuozhi ZhangXiujuan WuWenting YanAndi WanSiyi XiongLong YuanHao TianDandan MaJun JiangXiaowei QiYi Zhang
Published in: The oncologist (2024)
PLR and NLR could be used to predict the efficacy of neoadjuvant therapy with the taxane, anthracycline, and lobaplatin regimen for patients with TNBC, as patients who had lower PLR and NLR values had a higher tpCR rate and a better long-term prognosis.
Keyphrases
  • neoadjuvant chemotherapy
  • locally advanced
  • lymph node
  • rectal cancer
  • sentinel lymph node
  • squamous cell carcinoma
  • radiation therapy
  • stem cells
  • bone marrow
  • smoking cessation